A siRNA targets and inhibits a broad range of SARS‐CoV‐2 infections including Delta variantPan‐Chyr Yang, Shu‐Chen Hsu, Si‐Man Ieong et al.|EMBO Molecular Medicine|2022Cited by 66
Humanized COVID‐19 decoy antibody effectively blocks viral entry and prevents SARS‐CoV‐2 infectionKuo‐Yen Huang, Pan‐Chyr Yang, M. L. Lin et al.|EMBO Molecular Medicine|2020Cited by 64
Nanoparticle composite TPNT1 is effective against SARS-CoV-2 and influenza virusesSui‐Yuan Chang, Pan‐Chyr Yang, Kuo‐Yen Huang et al.|Scientific Reports|2021Cited by 42
Nanoparticle composite TPNT1 is effective against SARS-CoV-2 and influenza virusesSui‐Yuan Chang, Pan‐Chyr Yang, Kuo‐Yen Huang et al.|Research Square|2020Cited by 10